Filter
536
Filtered Results: 536
Text search:
Global
Health
Institute,
University
of
California
Featured
Recommendations
56
New Publications
102
Language
Document type
No document type
236
Studies & Reports
145
Guidelines
76
Manuals
50
Strategic & Response Plan
11
Training Material
7
Fact sheets
4
Situation Updates
3
Resource Platforms
3
App
1
Countries / Regions
Global
36
Africa
9
Latin America and the Carribbean
9
Ghana
7
Congo, Democratic Republic of
7
Brazil
7
India
7
Kenya
6
South Africa
6
Ukraine
5
Western and Central Europe
5
Liberia
5
Sierra Leone
4
Tanzania
4
Uganda
4
Mexico
3
Syria
3
Zimbabwe
3
Guinea
3
Mozambique
3
USA
3
Asia
3
Eastern Europe
3
Russia
3
Namibia
3
Zambia
3
Nepal
2
Colombia
2
Cameroon
2
Malawi
2
Guinea-Bissau
2
Germany
2
North America
2
Angola
2
North Macedonia
1
Tajikistan
1
Thailand
1
El Salvador
1
Lesotho
1
Rwanda
1
Chile
1
Nigeria
1
Albania
1
Canada
1
Laos
1
Senegal
1
Kyrgyzstan
1
Afghanistan
1
Morocco
1
Philippines
1
Haiti
1
Venezuela
1
Hungary
1
Jordan
1
West and Central Africa
1
Jamaica
1
France
1
Norway
1
Portugal
1
Southern Africa
1
Argentina
1
Lebanon
1
Bangladesh
1
Vietnam
1
Yemen
1
Georgia
1
Mali
1
Botswana
1
South Sudan
1
Indonesia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
82
Clinical Guidelines
82
Public Health
41
Women & Child Health
37
Key Resources
21
Pharmacy & Technologies
8
Capacity Building
2
Toolboxes
HIV
77
Planetary Health
71
Mental Health
45
TB
42
COVID-19
36
NTDs
31
Global Health Education
25
Caregiver
16
Disability
15
Rapid Response
14
NCDs
13
Ebola & Marburg
11
Malaria
10
Health Financing Toolbox
9
Natural Hazards
8
AMR
6
Refugee
5
Social Ethics
5
Pharmacy
3
Conflict
3
Zika
3
Polio
1
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Guideline
Iron deficiency is one of the most common forms of nutritional deficiencies, particularly among vulnerable groups such as women, children and low-income populations. Iron deficiency often precedes anaemia, and anaemia during pregnancy is one of the strongest predictors of anaemia duri...
Iron deficiency is one of the most common forms of nutritional deficiencies, particularly among vulnerable groups such as women, children and low-income populations. Iron deficiency often precedes anaemia, and anaemia during pregnancy is one of the strongest predictors of anaemia duri...
Rreport of a WHO Consultative Meeting Kolkata India 2012
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The objectives of this guideline are the same as those of the 2011 edition, namely to provide evidence-based normative guidance on interventions to improve adolescent morbidity and mortality by reducing the chances of early pregnancy and its resulting poor health outcomes. The specific objectives of...
Undernutrition increases the risk of tuberculosis (TB) and in turn TB can lead to malnutrition. Undernutrition is therefore highly prevalent among people with TB. It has been demonstrated that undernutrition is a risk factor for progression from TB infection to active TB disease and that undernutrit...
Results from studies evaluating the effectiveness of focused psychosocial support interventions in children exposed to traumatic events in humanitarian settings in low-income and middle-income countries have been inconsistent, showing varying results by setting and subgroup (eg, age or gender). We a...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Climate change is increasing the risks of injuries, diseases, and deaths globally. However, the association between ambient temperature and renal diseases has not been fully characterized. This study aimed to quantify the risk and attributable burden for hospitalizations of renal diseases related to...
This is the first guidance note in a four-part series of notes produced by InterAction to support management,
program and M&E staff in international NGOs to plan, design, manage, conduct and use impact evaluations. This first guidance note, Introduction to Impact Evaluation, provides an overview of...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
The Manual for Indoor Residual Spraying in Urban Areas for Aedes aegypti Control is intended not only for operational personnel and middle and senior management of programs responsible for the prevention and control of Aedes-borne diseases, but also for the academic community involved in Aedes resea...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
The primary audience for this guidance is persons
working directly in vector-borne disease prevention
and control, including programme managers,
researchers and field workers. A brief technical
background is provided for the benefit of persons
without expertise in vector-borne diseases; readers...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
